Investor Relations

Press Releases

Date Title and Summary View
Toggle Summary NanoString Technologies Releases Operating Results for First Quarter of 2020
SEATTLE --(BUSINESS WIRE)--May 7, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the first quarter of 2020. First Quarter Financial Highlights Product and service revenue of
View HTML
Toggle Summary Singapore Researchers Use NanoString’s nCounter Platform to Rapidly Profile the Response of the Immune System to the SARS-CoV-2 Virus
Scientists from the SingHealth Duke-NUS Academic Medical Centre in Singapore use Simplicity and Speed of nCounter to Publish Study Within Weeks of Infection NanoString Offers COVID-19 RNA Panel at no Charge for Research use Applications SEATTLE --(BUSINESS WIRE)--Apr.
View HTML
Toggle Summary NanoString Provides COVID-19 Business Update and Announces Conference Call on Thursday May 7th, 2020
GeoMx DSP Orders and Revenue In-Line with Prior Guidance nCounter Instrument and Consumable Revenue Disrupted by COVID-19 SEATTLE --(BUSINESS WIRE)--Apr. 6, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today
View HTML
Toggle Summary NanoString Technologies Announces Pricing of Upsized Offering of $200 Million of Convertible Senior Notes
SEATTLE, Wash. --(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced the pricing of $200 million aggregate principal amount of 2.625% convertible senior notes due 2025 in a private placement to qualified
View HTML
Toggle Summary NanoString Technologies Announces Proposed Private Offering of $175 Million of Convertible Senior Notes
SEATTLE --(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that it intends to offer, subject to market conditions and other factors, $175 million aggregate principal amount of convertible senior notes
View HTML
Toggle Summary NanoString Technologies Releases Fourth Quarter and Full Year 2019 Operating Results and Provides 2020 Financial Outlook
SEATTLE --(BUSINESS WIRE)--Feb. 26, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today reported financial results for the fourth quarter and year ended December 31, 2019 . Fourth Quarter Financial Highlights Product and
View HTML
Toggle Summary NanoString Highlights Groundbreaking Spatial Genomics Research Using Expanding Portfolio of GeoMx High-Plex RNA Atlas Products at 2020 Advances in Genome Biology and Technology (AGBT) Conference
Presenting Ten Research Studies using the Cancer Transcriptome Atlas to Discover Novel Biomarkers and First Data from Forthcoming Whole Transcriptome Atlas Unveiling GeoMx DSP Roadmap at 2 nd Annual Spatial Genomics Summit on Sun February 23 rd SEATTLE --(BUSINESS WIRE)--Feb.
View HTML
Toggle Summary NanoString to Present at the 40th Annual Cowen Healthcare Conference
SEATTLE --(BUSINESS WIRE)--Feb. 18, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the company’s management is scheduled to present at the 40 th Annual Cowen Healthcare Conference in Boston .
View HTML
Toggle Summary NanoString to Release Fourth Quarter and Fiscal Year 2019 Financial Results and Host Conference Call on Wednesday, February 26, 2020
SEATTLE --(BUSINESS WIRE)--Feb. 10, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced that the Company will release fourth quarter and fiscal year 2019 financial results after the close of the market on
View HTML
Toggle Summary Two Landmark Nature Publications use NanoString’s GeoMx Digital Spatial Profiling to Dissect Mechanisms of Response to Immunotherapy
Deep Molecular Profiling of Immune Cells Critical for Survival and Response to Therapy in Patients with Metastatic Melanoma SEATTLE --(BUSINESS WIRE)--Jan. 15, 2020-- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for translational research, today announced
View HTML